BiotechTube
Home/CytoMed Therapeutics/Wang Shu
WS

Wang Shu

Scientific Founder/Advisor

CytoMed Therapeutics

Therapeutic Areas

Oncology

CytoMed Therapeutics Pipeline

DrugIndicationPhase
CTM-N2DVarious Solid TumorsPreclinical
CTM-N2D-001Various Solid TumorsPhase 1
CTM-PNKHematological CancersPreclinical
iPSC-γδ NKT CellsCancer (Broad Spectrum)Research

Leadership Team at CytoMed Therapeutics

TW
Tan Wee Kiat
Scientific Founder/Advisor
ZJ
Zeng Jie
Scientific Founder/Advisor
TJ
Tay Joanne Chiao Mei
Senior Scientist
CC
Chen Chun
Scientist
View full CytoMed Therapeutics profile